CAGNETTA , Antonia

Last name: CAGNETTA

First name: Antonia

Institution: UNIGE

Links

2015 (v1)

Publication

Metadata-only

Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma

Cagnetta, Antonia Lovera, Davide Grasso, Raffaella

Ongoing genomic instability represents a hallmark of multiple myeloma (MM) cells, which manifests largely as whole chromosome- or translocation-based aneuploidy. Importantly, although it supports tumorigenesis, progression and, response to treatment in MM patients, it remains one of the least understood components of malignant transformation in...

Uploaded on: April 11, 2025
2019 (v1)

Publication

Metadata-only

Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach

Guolo, Fabio Minetto, Paola Clavio, Marino

No description

Uploaded on: April 14, 2023
2010 (v1)

Publication

Metadata-only

A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib

Cea, Michele Cirmena, Gabriella Garuti, Anna

No description

Uploaded on: April 14, 2023
2023 (v1)

Publication

Metadata-only

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma

Gelli, Elisa Soncini, Debora Becherini, Pamela

No description

Uploaded on: February 14, 2024
2020 (v1)

Publication

Metadata-only

Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas

Manconi, Lorenzo Coviello, Elisa Canale, Filippo

Cisplatin-containing salvage regimens followed by autologous hematopoietic stem cell (HSC) transplantation are the current standard of care for relapsed or refractory (R/R) lymphomas. We retrospectively analyzed efficacy and stem cell mobilizing activity of oxaliplatin, cytarabine, dexamethasone and rituximab (R-DHAOx) in 53 R/R diffuse large B...

Uploaded on: April 14, 2023
2018 (v1)

Publication

Metadata-only

A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML

Guolo, Fabio Minetto, Paola Kunkl, Annalisa

No description

Uploaded on: May 12, 2023
2018 (v1)

Publication

Metadata-only

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

MINETTO, PAOLA GUOLO, FABIO Clavio, Marino

No description

Uploaded on: April 14, 2023

CAGNETTA , Antonia

Recent uploads